Olof Ulf Stefan Björklund
Direttore/Membro del Consiglio presso ProNoxis AB
Posizioni attive di Olof Ulf Stefan Björklund
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
ProNoxis AB
 ProNoxis AB Pharmaceuticals: MajorHealth Technology ProNoxis AB develops small-molecule drugs to treat chronic inflammation. The company was founded in 2009 and is headquartered in Lund, Sweden. | Direttore/Membro del Consiglio | - | - |
| Swedish Pharmaceutical Society | Corporate Officer/Principal | - | - |
Storia della carriera di Olof Ulf Stefan Björklund
Precedenti posizioni note di Olof Ulf Stefan Björklund
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ANNEXIN PHARMACEUTICALS AB | Direttore/Membro del Consiglio | 01/01/2016 | - |
| OxyPharma AB | Presidente | - | - |
| Pharmacia AB | Corporate Officer/Principal | - | - |
Aprea Therapeutics AB
 Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Aprea Therapeutics AB operates as a holding company that provides research performed at Karolinska Institutet. It focuses its activities on discovery and development of novel anticancer compounds targeting the tumor suppressor protein. Its product has been tested in a Phase I/II dose escalating safety study in patients with refractory hematological malignancies or prostate carcinoma. It pursues the development of an anticancer drug, APR-246, which has p53-based mechanism for patients with ovarian cancer. The company was founded by Klas Gosta Wiman, Galina Selivanova, Vladimir Bykov, Wenjie Bao, Natalia Issaeva, and Staffan Strömblad in 2003 and is headquartered in Solna, Sweden. | Amministratore Delegato | - | 20/10/2014 |
| Direttore operativo | - | - |
Formazione di Olof Ulf Stefan Björklund
| University of Uppsala | Graduate Degree |
Statistiche
Distribuzione geografica
| Svezia | 8 |
Posizioni
| Director/Board Member | 2 |
| Corporate Officer/Principal | 2 |
| Chief Executive Officer | 1 |
Settori
| Health Technology | 5 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ANNEXIN PHARMACEUTICALS AB | Health Technology |
| Aziende private | 5 |
|---|---|
Aprea Therapeutics AB
Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Aprea Therapeutics AB operates as a holding company that provides research performed at Karolinska Institutet. It focuses its activities on discovery and development of novel anticancer compounds targeting the tumor suppressor protein. Its product has been tested in a Phase I/II dose escalating safety study in patients with refractory hematological malignancies or prostate carcinoma. It pursues the development of an anticancer drug, APR-246, which has p53-based mechanism for patients with ovarian cancer. The company was founded by Klas Gosta Wiman, Galina Selivanova, Vladimir Bykov, Wenjie Bao, Natalia Issaeva, and Staffan Strömblad in 2003 and is headquartered in Solna, Sweden. | Health Technology |
ProNoxis AB
ProNoxis AB Pharmaceuticals: MajorHealth Technology ProNoxis AB develops small-molecule drugs to treat chronic inflammation. The company was founded in 2009 and is headquartered in Lund, Sweden. | Health Technology |
| OxyPharma AB | |
| Swedish Pharmaceutical Society | |
| Pharmacia AB | Health Technology |
